|Title||A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma|
|Publication Type||Journal Article|
|Year of Publication||2005|
|Authors||Cascon, A, Ruiz-Llorente, S, Rodriguez-Perales, S, Honrado, E, Martinez-Ramirez, A, Leton, R, Montero-Conde, C, Benitez, J, Dopazo, J, Cigudosa, JC, Robledo, M|
|Journal||Genes Chromosomes Cancer|
|Keywords||80 and over Child Chromosomes; Adolescent Adrenal Gland Neoplasms/*genetics Adult Aged Aged; Biological/*genetics; Human; Pair 1/genetics Chromosomes; Pair 11/genetics Chromosomes; Pair 3/genetics Chromosomes; Pair 8/genetics Female Gene Deletion Head and Neck Neoplasms/*genetics Humans Male Middle Aged Nucleic Acid Hybridization Paraganglioma/*genetics Pheochromocytoma/*genetics Tumor Markers|
Although the histologic distinction between pheochromocytomas and head and neck paragangliomas is clear, little is known about the genetic differences between them. To date, various sets of genes have been found to be involved in inherited susceptibility to developing both tumor types, but the genes involved in sporadic pathogenesis are still unknown. To define new candidate regions, we performed CGH analysis on 29 pheochromocytomas and on 24 paragangliomas mainly of head and neck origin (20 of 24), which allowed us to differentiate between the two tumor types. Loss of 3q was significantly more frequent in pheochromocytomas, and loss of 1q appeared only in paragangliomas. We also found gain of 11q13 to be a significantly frequent alteration in malignant cases of both types. In addition, recurrent loss of 8p22-23 was found in 62% of pheochromocytomas (including all malignant cases) versus in 33% of paragangliomas, suggesting that this region contains candidate genes involved in the pathogenesis of this abnormality. Using FISH analysis on tissue microarrays, we confirmed genomic deletion of this region in 55% of pheochromocytomas compared to 12% of paragangliomas. Loss of 8p22-23 appears to be an important event in the sporadic development of these tumors, and additional molecular studies are necessary to identify candidate genes in this chromosomal region.
Cascon, Alberto Ruiz-Llorente, Sergio Rodriguez-Perales, Sandra Honrado, Emiliano Martinez-Ramirez, Angel Leton, Rocio Montero-Conde, Cristina Benitez, Javier Dopazo, Joaquin Cigudosa, Juan C Robledo, Mercedes Research Support, Non-U.S. Gov’t United States Genes, chromosomes & cancer Genes Chromosomes Cancer. 2005 Mar;42(3):260-8.